Gunderson Dettmer represented Lyndra Therapeutics on the deal Lyndra Therapeutics has raised $55 million in Series B financing, funds it will use for Phase II clinical…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now